NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,372 | +0.9% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $20,182 | +9.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $18,400 | +102122.2% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $18 | -99.9% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $15,000 | -11.8% | 200 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $17,000 | -5.6% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $18,000 | +5.9% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $17,000 | +6.2% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $16,000 | -11.1% | 200 | 0.0% | 0.00% | -69.2% |
| Q2 2021 | $18,000 | +5.9% | 200 | 0.0% | 0.01% | +8.3% |
| Q1 2021 | $17,000 | -22.7% | 200 | -13.8% | 0.01% | -29.4% |
| Q4 2020 | $22,000 | +29.4% | 232 | +16.0% | 0.02% | +21.4% |
| Q3 2020 | $17,000 | 0.0% | 200 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $17,000 | +6.2% | 200 | 0.0% | 0.02% | -11.1% |
| Q1 2020 | $16,000 | -15.8% | 200 | 0.0% | 0.02% | +5.9% |
| Q4 2019 | $19,000 | +11.8% | 200 | 0.0% | 0.02% | +6.2% |
| Q3 2019 | $17,000 | -5.6% | 200 | 0.0% | 0.02% | -5.9% |
| Q2 2019 | $18,000 | -5.3% | 200 | 0.0% | 0.02% | +54.5% |
| Q1 2019 | $19,000 | +11.8% | 200 | 0.0% | 0.01% | +22.2% |
| Q4 2018 | $17,000 | 0.0% | 200 | 0.0% | 0.01% | +12.5% |
| Q3 2018 | $17,000 | +13.3% | 200 | 0.0% | 0.01% | +14.3% |
| Q2 2018 | $15,000 | -6.2% | 200 | 0.0% | 0.01% | +16.7% |
| Q1 2018 | $16,000 | -5.9% | 200 | 0.0% | 0.01% | -14.3% |
| Q4 2017 | $17,000 | -29.2% | 200 | -29.6% | 0.01% | -46.2% |
| Q3 2017 | $24,000 | 0.0% | 284 | 0.0% | 0.01% | +18.2% |
| Q2 2017 | $24,000 | -45.5% | 284 | -51.9% | 0.01% | -45.0% |
| Q1 2017 | $44,000 | -27.9% | 591 | -29.1% | 0.02% | -35.5% |
| Q4 2016 | $61,000 | -92.5% | 834 | -91.9% | 0.03% | -91.3% |
| Q3 2016 | $814,000 | -75.6% | 10,308 | -74.5% | 0.36% | -72.0% |
| Q2 2016 | $3,337,000 | +13.3% | 40,447 | -0.5% | 1.28% | -5.4% |
| Q1 2016 | $2,946,000 | -99.9% | 40,670 | +9.6% | 1.35% | -8.9% |
| Q4 2015 | $3,193,805,000 | +111924.0% | 37,120 | +19.7% | 1.48% | -8.6% |
| Q3 2015 | $2,851,000 | +75.2% | 31,012 | +87.4% | 1.62% | +59.1% |
| Q2 2015 | $1,627,000 | -19.5% | 16,546 | -19.3% | 1.02% | -20.4% |
| Q1 2015 | $2,021,000 | – | 20,491 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |